These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 33723390)
21. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis. Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603 [TBL] [Abstract][Full Text] [Related]
22. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma. Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992 [TBL] [Abstract][Full Text] [Related]
23. HLA-DQB1*03 and DRB1*07 alleles increase the risk of cervical cancer among Uighur and Han women in Xinjiang, China. Hu JM; Liang WH; Qi CH; Wang XL; Pan XL; Qi LW; Shen XH; Li JF; Xie YF; Pang LJ; Liu CX; Zhang HJ; Tao L; Li F Future Oncol; 2018 Aug; 14(20):2005-2011. PubMed ID: 29513033 [TBL] [Abstract][Full Text] [Related]
24. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor. De Cecco L; Bossi P; Locati L; Canevari S; Licitra L Ann Oncol; 2014 Aug; 25(8):1628-35. PubMed ID: 24827125 [TBL] [Abstract][Full Text] [Related]
25. Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma. Pan XB; Lu Y; Huang JL; Long Y; Yao DS Aging (Albany NY); 2019 Nov; 11(22):10154-10166. PubMed ID: 31740624 [TBL] [Abstract][Full Text] [Related]
26. Identification of microRNA expression signature for the diagnosis and prognosis of cervical squamous cell carcinoma. Bozgeyik E; Tepe NB; Bozdag Z Pathol Res Pract; 2020 Nov; 216(11):153159. PubMed ID: 32841775 [TBL] [Abstract][Full Text] [Related]
27. Identification of Zhao S; Yu M DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248 [TBL] [Abstract][Full Text] [Related]
28. Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis. Sun F; Xiong Y; Zhou XH; Li Q; Xiao L; Long P; Li LJ; Cai MY; Wei YX; Ma YL; Yu YH Tumour Biol; 2016 May; 37(5):6729-36. PubMed ID: 26662108 [TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer. Luo M; Shen D; Wang W; Xian J Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262 [TBL] [Abstract][Full Text] [Related]
30. Identification of an immune-based mRNA-lncRNA signature for overall survival in cervical squamous cell carcinoma. Mao Y; Chen R; Xia M; Guo P; Zeng F; Huang J; He M Future Oncol; 2021 Jun; 17(18):2365-2380. PubMed ID: 33724869 [TBL] [Abstract][Full Text] [Related]
32. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion. Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940 [TBL] [Abstract][Full Text] [Related]
33. HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC. Hu JM; Li L; Chen YZ; Liu C; Cui X; Yin L; Yang L; Zou H; Pang L; Zhao J; Qi Y; Cao Y; Jiang J; Liang W; Li F Epigenetics; 2014 Oct; 9(10):1366-73. PubMed ID: 25437052 [TBL] [Abstract][Full Text] [Related]
34. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma. Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis. Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197 [TBL] [Abstract][Full Text] [Related]
36. Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations. Li N; Yu K; Lin Z; Zeng D Exp Biol Med (Maywood); 2022 Feb; 247(3):207-220. PubMed ID: 34674573 [TBL] [Abstract][Full Text] [Related]
37. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients. Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013 [TBL] [Abstract][Full Text] [Related]
38. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis. Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732 [TBL] [Abstract][Full Text] [Related]
39. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis. Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495 [TBL] [Abstract][Full Text] [Related]
40. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]